JAK2 and renal cell carcinoma: Mechanistically, downregulation of IL13Rα2 in RCC cells seemed to decrease the phosphorylation of JAK2 and increase expression of FOXO3, suggesting that IL13Rα2 probably is involved in the progression of RCC through JAK2/FOXO3 pathway (Figure 6).